POU2AF1 and plasma cell myeloma: Furthermore, our investigations extended to other POU2AF1 complex-dependent B cell malignancies, including multiple myeloma, wherein sensitivity to the mSWI/SNF ATPase PROTAC degrader was observed in vitro and in vivo.